The Incidence of Hepatitis C Among Gay, Bisexual, and Other Men Who Have Sex With Men in Australia, 2009–2019

Abstract Background Hepatitis C virus (HCV) infection has been reported among gay, bisexual, and other men who have sex with men (GBM) globally including GBM with human immunodeficiency virus (HIV) and HIV-negative GBM, particularly those using HIV preexposure prophylaxis (PrEP). In Australia, HCV d...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Clinical infectious diseases 2022-05, Vol.74 (10), p.1804-1811
Hauptverfasser: Harney, Brendan L, Sacks-Davis, Rachel, van Santen, Daniela K, Traeger, Michael, Wilkinson, Anna L, Asselin, Jason, El-Hayek, Carol, Fairley, Christopher K, Roth, Norman, Bloch, Mark, Matthews, Gail, Donovan, Basil, Guy, Rebecca, Stoové, Mark, Hellard, Margaret E, Doyle, Joseph S
Format: Artikel
Sprache:eng
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 1811
container_issue 10
container_start_page 1804
container_title Clinical infectious diseases
container_volume 74
creator Harney, Brendan L
Sacks-Davis, Rachel
van Santen, Daniela K
Traeger, Michael
Wilkinson, Anna L
Asselin, Jason
El-Hayek, Carol
Fairley, Christopher K
Roth, Norman
Bloch, Mark
Matthews, Gail
Donovan, Basil
Guy, Rebecca
Stoové, Mark
Hellard, Margaret E
Doyle, Joseph S
description Abstract Background Hepatitis C virus (HCV) infection has been reported among gay, bisexual, and other men who have sex with men (GBM) globally including GBM with human immunodeficiency virus (HIV) and HIV-negative GBM, particularly those using HIV preexposure prophylaxis (PrEP). In Australia, HCV direct-acting antiviral treatment (DAA) was government-funded from 2016. Large implementation studies of PrEP also began in 2016. We examined HCV incidence among GBM to assess whether HCV incidence has changed since 2015. Methods Data were drawn from the Australian Collaboration for Coordinated Enhanced Sentinel Surveillance. We included GBM who tested HCV antibody negative at their first test and had ≥1 subsequent test. Generalized linear modeling (Poisson distribution) was used to examine HCV incidence from 2009 to 2019 stratified by HIV status, and among HIV-negative GBM prescribed PrEP from 2016 to 2019. Results Among 6744 GBM with HIV, HCV incidence was 1.03 per 100 person-years (PY). Incidence declined by 78% in 2019 compared to 2015 (incidence rate ratio [IRR], 0.22 [95% confidence interval {CI}: .09–.55]). Among 20 590 HIV-negative GBM, HCV incidence was 0.20/100 PY, with no significant change over time. Among 11 661 HIV-negative GBM prescribed PrEP, HCV incidence was 0.29/100 PY. Compared to 2016, incidence among GBM prescribed PrEP declined by 80% in 2019 (IRR, 0.20 [95% CI: .06–.64]). Conclusions HCV incidence among GBM living with HIV declined following DAA availability. There was no observed change in HCV incidence among HIV-negative GBM overall. Among GBM prescribed PrEP, incidence declined since the early years of PrEP implementation in Australia. Australia is on track to eliminate HCV among GBM before global 2030 targets. Since the availability of direct-acting antiviral treatment and HIV preexposure prophylaxis in Australia, hepatitis C incidence declined among gay, bisexual, and other men who have sex with men with HIV and remained stable among those who are HIV negative.
doi_str_mv 10.1093/cid/ciab720
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_2586450476</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><oup_id>10.1093/cid/ciab720</oup_id><sourcerecordid>2586450476</sourcerecordid><originalsourceid>FETCH-LOGICAL-c320t-e48a5e00bd93afee8fa29cf8e8a59d0dbc7dfb9d6bfab273f45c3857d6351e123</originalsourceid><addsrcrecordid>eNp9kD1PwzAQQC0EoqUwsSNPCIkG7DhO7LFU0FYCdaCoY-TEZ2KUjxInqN34D_xDfgmBFkaG051OT294CJ1SckWJZNep1d2oJPLJHupTziIv5JLudzfhwgsEEz105NwLIZQKwg9RjwWhFIyJPqoWGeBZ2TmgTAFXBk9hpRrbWIfHeFRU5TOeqM0Q31gH61blQ6xKjedNBjV-gBIvswpP1RvgR1jjpW2yn68t8ah1Ta1yq4bYJ0R-vn_4hMpjdGBU7uBktwfo6e52MZ569_PJbDy691Lmk8aDQCgOhCRaMmUAhFG-TI2A7i010UkaaZNIHSZGJX7ETMBTJnikQ8YpUJ8N0MXWu6qr1xZcExfWpZDnqoSqdbHPRRhwEkRhh15u0bSunKvBxKvaFqrexJTE34Xjrk68K9zRZztxmxSg_9jfpB1wvgWqdvWv6Qupj4Nz</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2586450476</pqid></control><display><type>article</type><title>The Incidence of Hepatitis C Among Gay, Bisexual, and Other Men Who Have Sex With Men in Australia, 2009–2019</title><source>Oxford University Press Journals All Titles (1996-Current)</source><source>Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals</source><source>Alma/SFX Local Collection</source><creator>Harney, Brendan L ; Sacks-Davis, Rachel ; van Santen, Daniela K ; Traeger, Michael ; Wilkinson, Anna L ; Asselin, Jason ; El-Hayek, Carol ; Fairley, Christopher K ; Roth, Norman ; Bloch, Mark ; Matthews, Gail ; Donovan, Basil ; Guy, Rebecca ; Stoové, Mark ; Hellard, Margaret E ; Doyle, Joseph S</creator><creatorcontrib>Harney, Brendan L ; Sacks-Davis, Rachel ; van Santen, Daniela K ; Traeger, Michael ; Wilkinson, Anna L ; Asselin, Jason ; El-Hayek, Carol ; Fairley, Christopher K ; Roth, Norman ; Bloch, Mark ; Matthews, Gail ; Donovan, Basil ; Guy, Rebecca ; Stoové, Mark ; Hellard, Margaret E ; Doyle, Joseph S ; Australian Collaboration for Coordinated Enhanced Sentinel Surveillance of Sexually Transmissible Infections and Blood-borne Viruses (ACCESS)</creatorcontrib><description>Abstract Background Hepatitis C virus (HCV) infection has been reported among gay, bisexual, and other men who have sex with men (GBM) globally including GBM with human immunodeficiency virus (HIV) and HIV-negative GBM, particularly those using HIV preexposure prophylaxis (PrEP). In Australia, HCV direct-acting antiviral treatment (DAA) was government-funded from 2016. Large implementation studies of PrEP also began in 2016. We examined HCV incidence among GBM to assess whether HCV incidence has changed since 2015. Methods Data were drawn from the Australian Collaboration for Coordinated Enhanced Sentinel Surveillance. We included GBM who tested HCV antibody negative at their first test and had ≥1 subsequent test. Generalized linear modeling (Poisson distribution) was used to examine HCV incidence from 2009 to 2019 stratified by HIV status, and among HIV-negative GBM prescribed PrEP from 2016 to 2019. Results Among 6744 GBM with HIV, HCV incidence was 1.03 per 100 person-years (PY). Incidence declined by 78% in 2019 compared to 2015 (incidence rate ratio [IRR], 0.22 [95% confidence interval {CI}: .09–.55]). Among 20 590 HIV-negative GBM, HCV incidence was 0.20/100 PY, with no significant change over time. Among 11 661 HIV-negative GBM prescribed PrEP, HCV incidence was 0.29/100 PY. Compared to 2016, incidence among GBM prescribed PrEP declined by 80% in 2019 (IRR, 0.20 [95% CI: .06–.64]). Conclusions HCV incidence among GBM living with HIV declined following DAA availability. There was no observed change in HCV incidence among HIV-negative GBM overall. Among GBM prescribed PrEP, incidence declined since the early years of PrEP implementation in Australia. Australia is on track to eliminate HCV among GBM before global 2030 targets. Since the availability of direct-acting antiviral treatment and HIV preexposure prophylaxis in Australia, hepatitis C incidence declined among gay, bisexual, and other men who have sex with men with HIV and remained stable among those who are HIV negative.</description><identifier>ISSN: 1058-4838</identifier><identifier>EISSN: 1537-6591</identifier><identifier>DOI: 10.1093/cid/ciab720</identifier><identifier>PMID: 34698338</identifier><language>eng</language><publisher>US: Oxford University Press</publisher><ispartof>Clinical infectious diseases, 2022-05, Vol.74 (10), p.1804-1811</ispartof><rights>The Author(s) 2021. Published by Oxford University Press for the Infectious Diseases Society of America. All rights reserved. For permissions, e-mail: journals.permissions@oup.com. 2021</rights><rights>The Author(s) 2021. Published by Oxford University Press for the Infectious Diseases Society of America. All rights reserved. For permissions, e-mail: journals.permissions@oup.com.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c320t-e48a5e00bd93afee8fa29cf8e8a59d0dbc7dfb9d6bfab273f45c3857d6351e123</citedby><cites>FETCH-LOGICAL-c320t-e48a5e00bd93afee8fa29cf8e8a59d0dbc7dfb9d6bfab273f45c3857d6351e123</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,776,780,1578,27901,27902</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/34698338$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Harney, Brendan L</creatorcontrib><creatorcontrib>Sacks-Davis, Rachel</creatorcontrib><creatorcontrib>van Santen, Daniela K</creatorcontrib><creatorcontrib>Traeger, Michael</creatorcontrib><creatorcontrib>Wilkinson, Anna L</creatorcontrib><creatorcontrib>Asselin, Jason</creatorcontrib><creatorcontrib>El-Hayek, Carol</creatorcontrib><creatorcontrib>Fairley, Christopher K</creatorcontrib><creatorcontrib>Roth, Norman</creatorcontrib><creatorcontrib>Bloch, Mark</creatorcontrib><creatorcontrib>Matthews, Gail</creatorcontrib><creatorcontrib>Donovan, Basil</creatorcontrib><creatorcontrib>Guy, Rebecca</creatorcontrib><creatorcontrib>Stoové, Mark</creatorcontrib><creatorcontrib>Hellard, Margaret E</creatorcontrib><creatorcontrib>Doyle, Joseph S</creatorcontrib><creatorcontrib>Australian Collaboration for Coordinated Enhanced Sentinel Surveillance of Sexually Transmissible Infections and Blood-borne Viruses (ACCESS)</creatorcontrib><title>The Incidence of Hepatitis C Among Gay, Bisexual, and Other Men Who Have Sex With Men in Australia, 2009–2019</title><title>Clinical infectious diseases</title><addtitle>Clin Infect Dis</addtitle><description>Abstract Background Hepatitis C virus (HCV) infection has been reported among gay, bisexual, and other men who have sex with men (GBM) globally including GBM with human immunodeficiency virus (HIV) and HIV-negative GBM, particularly those using HIV preexposure prophylaxis (PrEP). In Australia, HCV direct-acting antiviral treatment (DAA) was government-funded from 2016. Large implementation studies of PrEP also began in 2016. We examined HCV incidence among GBM to assess whether HCV incidence has changed since 2015. Methods Data were drawn from the Australian Collaboration for Coordinated Enhanced Sentinel Surveillance. We included GBM who tested HCV antibody negative at their first test and had ≥1 subsequent test. Generalized linear modeling (Poisson distribution) was used to examine HCV incidence from 2009 to 2019 stratified by HIV status, and among HIV-negative GBM prescribed PrEP from 2016 to 2019. Results Among 6744 GBM with HIV, HCV incidence was 1.03 per 100 person-years (PY). Incidence declined by 78% in 2019 compared to 2015 (incidence rate ratio [IRR], 0.22 [95% confidence interval {CI}: .09–.55]). Among 20 590 HIV-negative GBM, HCV incidence was 0.20/100 PY, with no significant change over time. Among 11 661 HIV-negative GBM prescribed PrEP, HCV incidence was 0.29/100 PY. Compared to 2016, incidence among GBM prescribed PrEP declined by 80% in 2019 (IRR, 0.20 [95% CI: .06–.64]). Conclusions HCV incidence among GBM living with HIV declined following DAA availability. There was no observed change in HCV incidence among HIV-negative GBM overall. Among GBM prescribed PrEP, incidence declined since the early years of PrEP implementation in Australia. Australia is on track to eliminate HCV among GBM before global 2030 targets. Since the availability of direct-acting antiviral treatment and HIV preexposure prophylaxis in Australia, hepatitis C incidence declined among gay, bisexual, and other men who have sex with men with HIV and remained stable among those who are HIV negative.</description><issn>1058-4838</issn><issn>1537-6591</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2022</creationdate><recordtype>article</recordtype><recordid>eNp9kD1PwzAQQC0EoqUwsSNPCIkG7DhO7LFU0FYCdaCoY-TEZ2KUjxInqN34D_xDfgmBFkaG051OT294CJ1SckWJZNep1d2oJPLJHupTziIv5JLudzfhwgsEEz105NwLIZQKwg9RjwWhFIyJPqoWGeBZ2TmgTAFXBk9hpRrbWIfHeFRU5TOeqM0Q31gH61blQ6xKjedNBjV-gBIvswpP1RvgR1jjpW2yn68t8ah1Ta1yq4bYJ0R-vn_4hMpjdGBU7uBktwfo6e52MZ569_PJbDy691Lmk8aDQCgOhCRaMmUAhFG-TI2A7i010UkaaZNIHSZGJX7ETMBTJnikQ8YpUJ8N0MXWu6qr1xZcExfWpZDnqoSqdbHPRRhwEkRhh15u0bSunKvBxKvaFqrexJTE34Xjrk68K9zRZztxmxSg_9jfpB1wvgWqdvWv6Qupj4Nz</recordid><startdate>20220530</startdate><enddate>20220530</enddate><creator>Harney, Brendan L</creator><creator>Sacks-Davis, Rachel</creator><creator>van Santen, Daniela K</creator><creator>Traeger, Michael</creator><creator>Wilkinson, Anna L</creator><creator>Asselin, Jason</creator><creator>El-Hayek, Carol</creator><creator>Fairley, Christopher K</creator><creator>Roth, Norman</creator><creator>Bloch, Mark</creator><creator>Matthews, Gail</creator><creator>Donovan, Basil</creator><creator>Guy, Rebecca</creator><creator>Stoové, Mark</creator><creator>Hellard, Margaret E</creator><creator>Doyle, Joseph S</creator><general>Oxford University Press</general><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>20220530</creationdate><title>The Incidence of Hepatitis C Among Gay, Bisexual, and Other Men Who Have Sex With Men in Australia, 2009–2019</title><author>Harney, Brendan L ; Sacks-Davis, Rachel ; van Santen, Daniela K ; Traeger, Michael ; Wilkinson, Anna L ; Asselin, Jason ; El-Hayek, Carol ; Fairley, Christopher K ; Roth, Norman ; Bloch, Mark ; Matthews, Gail ; Donovan, Basil ; Guy, Rebecca ; Stoové, Mark ; Hellard, Margaret E ; Doyle, Joseph S</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c320t-e48a5e00bd93afee8fa29cf8e8a59d0dbc7dfb9d6bfab273f45c3857d6351e123</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2022</creationdate><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Harney, Brendan L</creatorcontrib><creatorcontrib>Sacks-Davis, Rachel</creatorcontrib><creatorcontrib>van Santen, Daniela K</creatorcontrib><creatorcontrib>Traeger, Michael</creatorcontrib><creatorcontrib>Wilkinson, Anna L</creatorcontrib><creatorcontrib>Asselin, Jason</creatorcontrib><creatorcontrib>El-Hayek, Carol</creatorcontrib><creatorcontrib>Fairley, Christopher K</creatorcontrib><creatorcontrib>Roth, Norman</creatorcontrib><creatorcontrib>Bloch, Mark</creatorcontrib><creatorcontrib>Matthews, Gail</creatorcontrib><creatorcontrib>Donovan, Basil</creatorcontrib><creatorcontrib>Guy, Rebecca</creatorcontrib><creatorcontrib>Stoové, Mark</creatorcontrib><creatorcontrib>Hellard, Margaret E</creatorcontrib><creatorcontrib>Doyle, Joseph S</creatorcontrib><creatorcontrib>Australian Collaboration for Coordinated Enhanced Sentinel Surveillance of Sexually Transmissible Infections and Blood-borne Viruses (ACCESS)</creatorcontrib><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Clinical infectious diseases</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Harney, Brendan L</au><au>Sacks-Davis, Rachel</au><au>van Santen, Daniela K</au><au>Traeger, Michael</au><au>Wilkinson, Anna L</au><au>Asselin, Jason</au><au>El-Hayek, Carol</au><au>Fairley, Christopher K</au><au>Roth, Norman</au><au>Bloch, Mark</au><au>Matthews, Gail</au><au>Donovan, Basil</au><au>Guy, Rebecca</au><au>Stoové, Mark</au><au>Hellard, Margaret E</au><au>Doyle, Joseph S</au><aucorp>Australian Collaboration for Coordinated Enhanced Sentinel Surveillance of Sexually Transmissible Infections and Blood-borne Viruses (ACCESS)</aucorp><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>The Incidence of Hepatitis C Among Gay, Bisexual, and Other Men Who Have Sex With Men in Australia, 2009–2019</atitle><jtitle>Clinical infectious diseases</jtitle><addtitle>Clin Infect Dis</addtitle><date>2022-05-30</date><risdate>2022</risdate><volume>74</volume><issue>10</issue><spage>1804</spage><epage>1811</epage><pages>1804-1811</pages><issn>1058-4838</issn><eissn>1537-6591</eissn><abstract>Abstract Background Hepatitis C virus (HCV) infection has been reported among gay, bisexual, and other men who have sex with men (GBM) globally including GBM with human immunodeficiency virus (HIV) and HIV-negative GBM, particularly those using HIV preexposure prophylaxis (PrEP). In Australia, HCV direct-acting antiviral treatment (DAA) was government-funded from 2016. Large implementation studies of PrEP also began in 2016. We examined HCV incidence among GBM to assess whether HCV incidence has changed since 2015. Methods Data were drawn from the Australian Collaboration for Coordinated Enhanced Sentinel Surveillance. We included GBM who tested HCV antibody negative at their first test and had ≥1 subsequent test. Generalized linear modeling (Poisson distribution) was used to examine HCV incidence from 2009 to 2019 stratified by HIV status, and among HIV-negative GBM prescribed PrEP from 2016 to 2019. Results Among 6744 GBM with HIV, HCV incidence was 1.03 per 100 person-years (PY). Incidence declined by 78% in 2019 compared to 2015 (incidence rate ratio [IRR], 0.22 [95% confidence interval {CI}: .09–.55]). Among 20 590 HIV-negative GBM, HCV incidence was 0.20/100 PY, with no significant change over time. Among 11 661 HIV-negative GBM prescribed PrEP, HCV incidence was 0.29/100 PY. Compared to 2016, incidence among GBM prescribed PrEP declined by 80% in 2019 (IRR, 0.20 [95% CI: .06–.64]). Conclusions HCV incidence among GBM living with HIV declined following DAA availability. There was no observed change in HCV incidence among HIV-negative GBM overall. Among GBM prescribed PrEP, incidence declined since the early years of PrEP implementation in Australia. Australia is on track to eliminate HCV among GBM before global 2030 targets. Since the availability of direct-acting antiviral treatment and HIV preexposure prophylaxis in Australia, hepatitis C incidence declined among gay, bisexual, and other men who have sex with men with HIV and remained stable among those who are HIV negative.</abstract><cop>US</cop><pub>Oxford University Press</pub><pmid>34698338</pmid><doi>10.1093/cid/ciab720</doi><tpages>8</tpages></addata></record>
fulltext fulltext
identifier ISSN: 1058-4838
ispartof Clinical infectious diseases, 2022-05, Vol.74 (10), p.1804-1811
issn 1058-4838
1537-6591
language eng
recordid cdi_proquest_miscellaneous_2586450476
source Oxford University Press Journals All Titles (1996-Current); Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals; Alma/SFX Local Collection
title The Incidence of Hepatitis C Among Gay, Bisexual, and Other Men Who Have Sex With Men in Australia, 2009–2019
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-31T13%3A29%3A00IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=The%20Incidence%20of%20Hepatitis%20C%20Among%20Gay,%20Bisexual,%20and%20Other%20Men%20Who%20Have%20Sex%20With%20Men%20in%20Australia,%202009%E2%80%932019&rft.jtitle=Clinical%20infectious%20diseases&rft.au=Harney,%20Brendan%20L&rft.aucorp=Australian%20Collaboration%20for%20Coordinated%20Enhanced%20Sentinel%20Surveillance%20of%20Sexually%20Transmissible%20Infections%20and%20Blood-borne%20Viruses%20(ACCESS)&rft.date=2022-05-30&rft.volume=74&rft.issue=10&rft.spage=1804&rft.epage=1811&rft.pages=1804-1811&rft.issn=1058-4838&rft.eissn=1537-6591&rft_id=info:doi/10.1093/cid/ciab720&rft_dat=%3Cproquest_cross%3E2586450476%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2586450476&rft_id=info:pmid/34698338&rft_oup_id=10.1093/cid/ciab720&rfr_iscdi=true